With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Modeling Pediatric Leukemia in Zebra Fish to Enable Discovery of New Anti- Leukemic Compounds||University of California, San Diego / David Traver, MD||Innovation Grants||2010||California|
|Targeting Neovascularization in Graft-Versus-Host Disease||Memorial Sloan-Kettering Cancer Center / Marcel van den Brink||Innovation Grants||2010||New York|
|Elucidating the Initiation Mechanism of the Fanconi Anemia Pathway of DNA Damage Repair||Yale School of Medicine / Yong Xiong||Innovation Grants||2010||Connecticut|
|Treating Brain Tumor by Changing Cell Division Pattern||Yale School of Medicine / Weimin Zhong||Innovation Grants||2010||Connecticut|
|A novel compound for treatment of T cell leukemia||Huntsman Cancer Institute / Nikolaus Trede||Innovation Grants||2010||Utah|
|Understanding the Role of a Novel Hereditary Cancer Gene||University of Texas Health Science Center at San Antonio / Patricia Dahia||Innovation Grants||2010||Texas|
|Pathogenesis of T-cell Acute Lymphoblastic Leukemia from Myeloproliferative Disorder||Duke University / Motonari Kondo||Innovation Grants||2010||North Carolina|
|Novel Therapeutic Target in Leukemia Stem Cells||Cincinnati Children's Hospital Medical Center / James Mulloy||Innovation Grants||2010||Ohio|
|Discovery of Inhibitors of MLL Fusion Proteins as Targeted Therapies for Pediatric Acute Leukemia||Nemours Center for Childhood Cancer Research / Andrew Napper||Innovation Grants||2010||Delaware|
|Identification of New Therapeutic Targets in Pediatric Acute Lymphoblastic Leukemia Through Mosaic Trisomy and Aneuploidy-Based Synthetic Lethality Screens||Dana-Farber Cancer Institute / David Pellman||Innovation Grants||2010||Massachusetts|